Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Measuring financial toxicity in myeloma: important considerations for clinical practice

In this video, Matthew LeBlanc, PhD, RN, University of North Carolina, Chapel Hill, NC, shares some insights into the importance of measuring financial toxicity in multiple myeloma, highlighting various tools used to measure this. Dr LeBlanc also challenges the approach of using health-related quality of life (HRQoL) to measure financial toxicity, and further discusses factors to consider when bringing this into clinical practice. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.